ArticleTheranostics2020

Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.